Digital substance use management platform Pelago, formerly Quit Genius, announced it secured $58 million in Series C funding, bringing its total raise to $151 million.
Existing investor Atomico led the round, with participation from other continuing investors, including Octopus Ventures, Y Combinator and Kinnevik AB. New investors GreyMatter Capital and Eight Roads also participated.
Laura...
In the midst of the COVID-19 pandemic, U.S. drug overdose deaths have surged. The CDC estimates that more than 107,000 people died in 2021, an increase of nearly 15% from the more than 93,000 deaths in 2020.
But the pandemic also has brought a sudden boost in telehealth utilization. Regulations surrounding telehealth prescriptions of controlled substances were loosened during the public health...
Virtual alcohol use disorder treatment company Ria Health completed an $18 million Series A funding round led by SV Health Investors.
Other participants in the round include SV limited partners, BPEA Private Equity and previous investor SOSV.
WHAT IT DOES
Ria provides virtual care for alcohol use disorder, including medication-assisted treatment like naltrexone, acamprosate and gabapentin that...
Virtual addiction treatment startup Boulder Care announced Friday it had received $36 million in Series B funding.
The round included participation by Qiming Venture Partners, Goodwater Capital and Laerdal Million Lives Fund as well as returning investors First Round Capital, Greycroft, Tusk Venture Partners and Gaingels.
Boulder said the Series B brings its total raise to more than $50 million....
Virtual addiction treatment Workit Health raised $118 million in Series C funding led by Insight Partners.
Other investors participating in the round include CVS Health Ventures, FirstMark Capital, BCBS Venture Fund, and 3L Capital.
"Workit is at the forefront of massive acceleration in telemedicine adoption, which is key to solving the overdose crisis that was exacerbated by COVID-19. The risk...
Quit Genius, a digital treatment platform for addiction, closed a $64 million Series B funding round. The round was co-led by Kinnevik and Atomico, with additional participation from Octopus Ventures, Triple Point Ventures and Startup Health.
This, in addition to the company's Series A round from last year, brings its total amount raised to $77.5 million.
WHAT THEY DO
Quit Genius offers treatment...
A recent study published in the Journal of Medical Internet Research (JMIR) shows initial support for a new version of Woebot – a text-based chatbot app designed to address mental health issues – that is designed to reduce substance use and other measures tied to substance use disorder (SUD).
Conducted by researchers from Stanford University School of Medicine and Woebot Health, the investigation...
About the authors: Dr. Sofia Noori (@sofianoori) was a member of the 2019 Flare Capital Partners Scholar Class and is currently a psychiatry resident at Yale School of Medicine. She is the curriculum lead for Innovation to Impact, a substance use entrepreneurship program funded by the National Institute for Drug Abuse.
Dr. Dan Gebremedhin (@dangebremedhin) is a partner at Flare Capital Partners...
axialHealthcare, maker of a platform for managing substance use disorder (SUD) patients, has closed $15 million in Series C funding. The raise was headlined by the Nashville company's existing investors, a list that includes Oak HC/FT, .406 Ventures, BlueCross BlueShield Venture Partners and Sandbox Advantage Fund.
WHAT THEY DO
Founded in 2012, axialHealthcare's earlier iteration focused on...
Having a baby can be complicated and requires regular doctors visits and classes. Mix those challenges with managing a substance abuse disorder, and the result can be overwhelming.
iTether Technologies and University of Arizona physician Dr. Maria Manriquez have teamed up to develop a new app specifically designed to address the needs of pregnant women who are also dealing with opioid addiction...
_8_20.jpeg?itok=yaie-bYS)
